Ironwood Pharmaceuticals (IRWD) Other Gross PP&E Adjustments (2016 - 2025)
Ironwood Pharmaceuticals' Other Gross PP&E Adjustments history spans 16 years, with the latest figure at -$3.6 million for Q4 2025.
- For Q4 2025, Other Gross PP&E Adjustments rose 52.62% year-over-year to -$3.6 million; the TTM value through Dec 2025 reached -$3.6 million, up 52.62%, while the annual FY2025 figure was -$3.6 million, 52.62% up from the prior year.
- Other Gross PP&E Adjustments for Q4 2025 was -$3.6 million at Ironwood Pharmaceuticals, up from -$9.8 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at -$3.6 million in Q4 2025 and bottomed at -$17.3 million in Q2 2021.
- The 5-year median for Other Gross PP&E Adjustments is -$12.8 million (2023), against an average of -$12.5 million.
- The largest annual shift saw Other Gross PP&E Adjustments increased 1.9% in 2023 before it skyrocketed 52.62% in 2025.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at -$15.0 million in 2021, then grew by 29.11% to -$10.6 million in 2022, then increased by 1.9% to -$10.4 million in 2023, then increased by 26.44% to -$7.7 million in 2024, then surged by 52.62% to -$3.6 million in 2025.
- Per Business Quant, the three most recent readings for IRWD's Other Gross PP&E Adjustments are -$3.6 million (Q4 2025), -$9.8 million (Q3 2025), and -$10.2 million (Q2 2025).